Slideshow
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
This slideshow reviews bosutinib (Bosulif), indicated for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome (Ph)-positive chronic myeloid leukemia (CML) with resistance or intolerance to prior therapy.
Table of Contents
Slide 4: Dosage and Administration
Slide 11: Cautions, Effects, and Interactions
Slide 18: What to Tell Your Patient
Slide 27: Reference